Teshima T - Search Results

1

Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis.

Reddy P, Teshima T, Kukuruga M, Ordemann R, Liu C, Lowler K, Ferrara JL. Reddy P, et al. Among authors: teshima t. J Exp Med. 2001 Nov 19;194(10):1433-40. doi: 10.1084/jem.194.10.1433. J Exp Med. 2001. PMID: 11714750 Free PMC article.

2

IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.

Teshima T, Hill GR, Pan L, Brinson YS, van den Brink MR, Cooke KR, Ferrara JL. Teshima T, et al. J Clin Invest. 1999 Aug;104(3):317-25. doi: 10.1172/JCI7111. J Clin Invest. 1999. PMID: 10430613 Free PMC article.

3

LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.

Cooke KR, Gerbitz A, Crawford JM, Teshima T, Hill GR, Tesolin A, Rossignol DP, Ferrara JL. Cooke KR, et al. Among authors: teshima t. J Clin Invest. 2001 Jun;107(12):1581-9. doi: 10.1172/JCI12156. J Clin Invest. 2001. PMID: 11413166 Free PMC article.

4

Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease.

Pan L, Teshima T, Hill GR, Bungard D, Brinson YS, Reddy VS, Cooke KR, Ferrara JL. Pan L, et al. Among authors: teshima t. Blood. 1999 Jun 15;93(12):4071-8. Blood. 1999. PMID: 10361103 Free article.

5

Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease.

Krijanovski OI, Hill GR, Cooke KR, Teshima T, Crawford JM, Brinson YS, Ferrara JL. Krijanovski OI, et al. Among authors: teshima t. Blood. 1999 Jul 15;94(2):825-31. Blood. 1999. PMID: 10397751 Free article.

6

Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia.

Hill GR, Teshima T, Gerbitz A, Pan L, Cooke KR, Brinson YS, Crawford JM, Ferrara JL. Hill GR, et al. Among authors: teshima t. J Clin Invest. 1999 Aug;104(4):459-67. doi: 10.1172/JCI6896. J Clin Invest. 1999. PMID: 10449438 Free PMC article.

7

The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity.

Hill GR, Teshima T, Rebel VI, Krijanovski OI, Cooke KR, Brinson YS, Ferrara JL. Hill GR, et al. Among authors: teshima t. J Immunol. 2000 Jan 15;164(2):656-63. doi: 10.4049/jimmunol.164.2.656. J Immunol. 2000. PMID: 10623807

8

G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient.

Reddy V, Hill GR, Pan L, Gerbitz A, Teshima T, Brinson Y, Ferrara JL. Reddy V, et al. Among authors: teshima t. Transplantation. 2000 Feb 27;69(4):691-3. doi: 10.1097/00007890-200002270-00041. Transplantation. 2000. PMID: 10708136

9

Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation.

Teshima T, Mach N, Hill GR, Pan L, Gillessen S, Dranoff G, Ferrara JL. Teshima T, et al. Cancer Res. 2001 Jan 1;61(1):162-71. Cancer Res. 2001. PMID: 11196155

10

Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect.

Schmaltz C, Alpdogan O, Horndasch KJ, Muriglan SJ, Kappel BJ, Teshima T, Ferrara JL, Burakoff SJ, van den Brink MR. Schmaltz C, et al. Among authors: teshima t. Blood. 2001 May 1;97(9):2886-95. doi: 10.1182/blood.v97.9.2886. Blood. 2001. PMID: 11313285 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,120 results

Search Page

Filters